3.Pulmonary Infection after Liver Transplantation:A Clinical Analysis
Min YI ; Xi ZHU ; Tonglin ZHANG
Chinese Journal of Nosocomiology 2006;0(02):-
OBJECTIVE To analyze the risk factors of pulmonary infection after liver transplantation and improve treatment strategy.METHODS Forty six adult patients who underwent liver transplantation were divided into two groups: pulmonary infection group and non-pulmonary infection group.An analysis was performed for the commonly used variables.RESULTS The frequency of pulmonary infection after liver transplantation was 43.5%,the mortality rate in the patients who developed pulmonary infection was 60%.Intraoperative total fluid perfusion, mechanical ventilatory time,serum creatinine,albumin,abdominal bleeding,and hydrothorax after liver transplantation were risk factors of pulmonary infection(P
4.Peripherally inserted central catheter in severely ill patients: A prospective,randomized,controlled study
Min YI ; Xi ZHU ; Haohui CHEN
Chinese Journal of Minimally Invasive Surgery 2001;0(03):-
Objective To compare the clinical application between peripherally inserted central catheterization(PICC) and subclavian central venous catheterization in severely ill patients.Methods A prospective study was carried out in 80 severely ill patients who had been randomly divided into two groups: receiving either PICC(PICC Group,40 patients) or subclavian central venous catheterization(Subclavian Group,40 patients).The success rate,the puncturing time,and the incidence of adverse reactions in the two groups were observed.Results The rate of successful puncture on one session was higher in the PICC Group(92.5%) than in the Subclavian Group(75.0%)(?2=4.501,P=0.034).And as compared with the Subclavian Group,the PICC Group reported a shorter puncturing time(15.7?5.3 min vs 23.9?6.3 min;t=-6.263,P=0.000) and a lower rate of adverse reactions(10.0% vs 27.5%;?2=4.021,P=0.045).Conclusions Use of peripherally inserted central catheterization is simple and safe to perform,superior to subclavian central venous catheterization.
5.Distribution and antimicrobial resistance of pathogens from intensive care unit patients’sputum obtained through fiberbronchoscope for four consec-utive years
Xiaomeng ZHU ; Yao LIU ; Yi WANG ; Xiaojing XI ; Xiangyou YU
Chinese Journal of Infection Control 2016;15(2):88-92
Objective To investigate the distribution and antimicrobial resistance of pathogens from lower respira-tory tract in patients in intensive care unit (ICU),so as to provide reference for clinical treatment.Methods Distri-bution and antimicrobial susceptibility of pathogens isolated from ICU patients’sputum obtained through fiberbron-choscope between 2011 and 2014 were analyzed retrospectively.Results A total of 3 454 pathogenic strains were isolated between January 1 ,2011 and December 31 ,2014,the percentage of gram-negative bacteria,gram-positive bacteria,and fungi were 84.11 %,14.50%,and 1 .39% respectively.The detection rates of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp .in 2011 -2014 were 38.46% -73.33% and 26.95% -37.06% respectively. Enterobacteriaceae strains had low resistance rates to imipenem and meropenem (<20.00%);resistance of Acinetobacter baumannii was higher than Pseudomonas aeruginosa ,both had low resistance rates to amikacin(3.32%-37.16%);vancomycin-and linezolid-resistant strains were not found among Staphylo-coccus .In 2011 - 2014,detection rates of methicillin-resistant Staphylococcus aureus (MRSA)were 42.86% -61 .22%,methicillin-resistant coagulase-negative staphylococcus (MRCNS)were 86.96% - 91 .67%;resistance rates of Enterococcus faecium was higher than Enterococcus faecalis ,vancomycin-resistant strains were not found among Enterococcus faecalis and Enterococcus faecium ;the major fungus was Candida albicans .Conclusion Anti-microbial resistance of pathogens isolated from lower respiratory tract is getting more serious,clinicians should pay attention to non-antimicrobial infection control strategies in addition to rational use of antimicrobial agents.
8.Synthesis of ornithine peptidomimetic efflux pump inhibitors and synergistic antibiotic activity against Pseudomonas aeruginosa
Xi ZHU ; Xi-can MA ; Xin-tong ZHANG ; Yi-shuang LIU ; Ning HE ; Yun-ying XIE ; Dan-qing SONG
Acta Pharmaceutica Sinica 2024;59(6):1720-1729
In order to solve the problem of resistance of
9.Preventive effects of ulinastatin on acute respiratory distress syndrome
Lijing JIA ; Liang YI ; Zhixu YANG ; Shupeng WANG ; Gang LI ; Xi ZHU
Journal of Peking University(Health Sciences) 2016;48(4):672-679
Objective:To explore the effect of ulinastatin on prevention of acute respiratory distress syn-drome (ARDS).Methods:A prospective multicentral cohort study was conducted.The patients from three intensive care units (ICUs)of grade A tertiary hospitals in Beijing and a ICU of grade A tertiary hospitals in Cangzhou from January 2012 to December 2014,included 77 ARDS at-risk patients with uli-nastatin treatment and 108 ARDS at-risk patients without ulinastatin treatment (control)were eligible. Both groups received normal treatment;additionally,the intervention group received 600 000 units of uli-nastatin via intravenous infusion for 5 days.The control group received the same amount of saline via in-travenous infusion for 5 days.Venous blood human neutrophil elastase (HNE)and peptidase inhibitor 3 (PI3)levels were measured on days 1,3,and 7,respectively.Other outcomes included acute physiolo-gy and chronic health evaluation scoring Ⅱ (APACHE Ⅱ),body temperature,respiratory rate,heart rate,mean arterial pressure,white blood cell counts,PaO2 /FiO2 ,ARDS incident,mechanical ventila-tion time,ICU treatment and hospitalization duration,28 days mortality.Results:The PI3 levels showed no statistical difference on day 1,but significant differences on day 3 and day 7 between the two groups (P <0.01).HNE /PI3 ratio showed no statistical difference on day 1,but significant differences on day 3 and day 7 (P <0.05).PaO2 /FiO2 was significantly higher in ulinastatin group on day 3 and day 7 (P <0.05).The incident rate for ulinastatin group was 15.58%,lower than that for the control group (33.33%),and the difference was statistically significant (P <0.05).The mechanical ventilation time and ICU treatment time in ulinastatin group was shorter than that in the control group,and the difference was statistically significant (P <0.05).There were no significant effects in other factors.Conclusion:Increased dose of ulinastatin can recover the balance of HNE and its antagonist,lower the HNE’s damage to lungs,and further reduce the ARDS incident rate.
10.Expression changes of HIF-1α, ROCK-2, FoxM1 in the lead acetate-induced injury in PC12 cells
Yongjin LI ; Yi ZHANG ; Kaiyong YANG ; Ke XI ; Shaoqiu LI ; Chunxue ZHU ; Yuefang CHEN ; Xiaojia HUANG
Chinese Pharmacological Bulletin 2015;(11):1562-1568
Aim To investigate the expression and im-plication of HIF-1α, ROCK-2 , FoxM1 in PC12 cell in-jury induced by lead acetate. Methods PC12 cells were treated with lead acetate at the doses of 100 , 200 and 400 μmol·L-1 . The cell viability was determined by MTT reduction assay and LDH assay, the intracellu-lar production of oxygen species was measured by as-sessing SOD and MDA levels, cell apoptosis was deter-mined by Hoechst 33342 staining, the expressions of HIF-1α, ROCK-2 , FoxM1 , Bcl-2 and Bax were deter-mined by immunoblotting analysis. Results Lead ac-etate induced cell injury in PC12 cells in a dose-de-pendent manner, and it potentiated oxygen radical pro-duction and cell apoptosis. In addition, lead acetate enhanced HIF-1α and ROCK-2 expressions, increased Bax/Bcl-2 ratio and decreased FoxM1 expression. Conclusion Lead acetate can induce PC12 cell apop-tosis, which may be related with the expressions of HIF-1α, ROCK-2 and FoxM1 . Cellular oxidative stress may contribute to the injury as well.